The vaccine, tailor-made to the genetic sequence of a patient’s cancer and paired with existing treatment, has the potential to be a game-changer.

At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…

News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers